Overview

Symbicort Onset of Action 2

Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to compare the early onset of effect of Symbicort compared to Advair Diskus and Ventolin in adults with asthma
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
AstraZeneca
Treatments:
Albuterol
Budesonide
Budesonide, Formoterol Fumarate Drug Combination
Fluticasone
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Fluticasone-Salmeterol Drug Combination
Formoterol Fumarate
Salmeterol Xinafoate
Criteria
Inclusion Criteria:

- At least 18 years of age

- Diagnosis of asthma and baseline lung function test results as determined by the
protocol

- Required and received inhaled corticosteroids within timeframe and doses specified in
the protocol

Exclusion Criteria:

- Severe asthma or asthma that is markedly effected by seasonal factors

- Has required and received non-inhaled corticosteroids within the previous 4 weeks, has
sensitivity to drugs specified in the protocol or requires treatment with
beta-blockers